BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 15867096)

  • 1. PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis.
    Dakic A; Metcalf D; Di Rago L; Mifsud S; Wu L; Nutt SL
    J Exp Med; 2005 May; 201(9):1487-502. PubMed ID: 15867096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors.
    DeKoter RP; Walsh JC; Singh H
    EMBO J; 1998 Aug; 17(15):4456-68. PubMed ID: 9687512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient expression of PU.1 commits multipotent progenitors to a myeloid fate whereas continued expression favors macrophage over granulocyte differentiation.
    McIvor Z; Hein S; Fiegler H; Schroeder T; Stocking C; Just U; Cross M
    Exp Hematol; 2003 Jan; 31(1):39-47. PubMed ID: 12543105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor.
    Dahl R; Walsh JC; Lancki D; Laslo P; Iyer SR; Singh H; Simon MC
    Nat Immunol; 2003 Oct; 4(10):1029-36. PubMed ID: 12958595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PU.1 immortalizes hematopoietic progenitors in a GM-CSF-dependent manner.
    Houston IB; Huang KJ; Jennings SR; DeKoter RP
    Exp Hematol; 2007 Mar; 35(3):374-384. PubMed ID: 17309818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PU.1 and the granulocyte- and macrophage colony-stimulating factor receptors play distinct roles in late-stage myeloid cell differentiation.
    Anderson KL; Smith KA; Perkin H; Hermanson G; Anderson CG; Jolly DJ; Maki RA; Torbett BE
    Blood; 1999 Oct; 94(7):2310-8. PubMed ID: 10498603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vivo Deletion of the Cebpa +37 kb Enhancer Markedly Reduces Cebpa mRNA in Myeloid Progenitors but Not in Non-Hematopoietic Tissues to Impair Granulopoiesis.
    Guo H; Cooper S; Friedman AD
    PLoS One; 2016; 11(3):e0150809. PubMed ID: 26937964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors.
    Nutt SL; Metcalf D; D'Amico A; Polli M; Wu L
    J Exp Med; 2005 Jan; 201(2):221-31. PubMed ID: 15657291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PU.1 Is Required for the Developmental Progression of Multipotent Progenitors to Common Lymphoid Progenitors.
    Pang SHM; de Graaf CA; Hilton DJ; Huntington ND; Carotta S; Wu L; Nutt SL
    Front Immunol; 2018; 9():1264. PubMed ID: 29942304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell fate specification: role of master regulatory switch transcription factor PU.1 in differential hematopoiesis.
    Gangenahalli GU; Gupta P; Saluja D; Verma YK; Kishore V; Chandra R; Sharma RK; Ravindranath T
    Stem Cells Dev; 2005 Apr; 14(2):140-52. PubMed ID: 15910240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of the tumor suppressor p15Ink4b enhances myeloid progenitor formation from common myeloid progenitors.
    Rosu-Myles M; Taylor BJ; Wolff L
    Exp Hematol; 2007 Mar; 35(3):394-406. PubMed ID: 17309820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commitment to the monocytic lineage occurs in the absence of the transcription factor PU.1.
    Henkel GW; McKercher SR; Leenen PJ; Maki RA
    Blood; 1999 May; 93(9):2849-58. PubMed ID: 10216079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subversion of T lineage commitment by PU.1 in a clonal cell line system.
    Dionne CJ; Tse KY; Weiss AH; Franco CB; Wiest DL; Anderson MK; Rothenberg EV
    Dev Biol; 2005 Apr; 280(2):448-66. PubMed ID: 15882585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2A Antagonizes PU.1 Activity through Inhibition of DNA Binding.
    Rogers JH; Owens KS; Kurkewich J; Klopfenstein N; Iyer SR; Simon MC; Dahl R
    Biomed Res Int; 2016; 2016():3983686. PubMed ID: 26942192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transcription factor PU.1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner.
    Carotta S; Dakic A; D'Amico A; Pang SH; Greig KT; Nutt SL; Wu L
    Immunity; 2010 May; 32(5):628-41. PubMed ID: 20510871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation.
    Iwasaki H; Somoza C; Shigematsu H; Duprez EA; Iwasaki-Arai J; Mizuno S; Arinobu Y; Geary K; Zhang P; Dayaram T; Fenyus ML; Elf S; Chan S; Kastner P; Huettner CS; Murray R; Tenen DG; Akashi K
    Blood; 2005 Sep; 106(5):1590-600. PubMed ID: 15914556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch signaling induces multilineage myeloid differentiation and up-regulates PU.1 expression.
    Schroeder T; Kohlhof H; Rieber N; Just U
    J Immunol; 2003 Jun; 170(11):5538-48. PubMed ID: 12759431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocytic differentiation of normal hematopoietic precursor cells induced by transcription factor PU.1 correlates with negative regulation of the c-myb promoter.
    Bellon T; Perrotti D; Calabretta B
    Blood; 1997 Sep; 90(5):1828-39. PubMed ID: 9292515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of PU.1 concentration in hematopoietic lineage commitment and maturation.
    Dahl R; Simon MC
    Blood Cells Mol Dis; 2003; 31(2):229-33. PubMed ID: 12972030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cartography of hematopoietic stem cell commitment dependent upon a reporter for transcription factor activation.
    Akashi K
    Ann N Y Acad Sci; 2007 Jun; 1106():76-81. PubMed ID: 17360807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.